ABBOTT MEDICAL NORWAY AS: årsregnskap 2023 vs 2022
Grew 18% on revenue, stronger earnings
approved 2024-06-21; registry 2024-07-01; journal 2024 554364
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for ABBOTT MEDICAL NORWAY AS. Revenue 140.29m NOK → 165.88m NOK (+18.2%). Net result +3.17m NOK → +4.36m NOK. Equity 24.81m NOK → 29.17m NOK.
On the constructive side: revenue rose; operating result improved; net result improved.
Also worth watching: payroll increased; cogs moved. All figures are taken from the published annual accounts for ABBOTT MEDICAL NORWAY AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 140.29m NOK to 165.88m NOK (+18.2% YoY). Calculated
-
↑
Operating result improved
Operating result +4.10m NOK → +5.35m NOK (op. margin 2.9% → 3.2%). Calculated
-
↑
Net result improved
Net result +3.17m NOK → +4.36m NOK (net margin 2.3% → 2.6%). Calculated
-
↑
Equity strengthened
Book equity 24.81m NOK → 29.17m NOK (equity ratio 43.1% → 50.1%). Calculated
-
↑
Cash rose
Bank deposits 12.02m NOK → 15.05m NOK (+25.2% YoY). Calculated
Things to notice
-
·
Payroll increased
Salary cost 17.29m NOK → 19.24m NOK (12% → 12% of revenue). Calculated
-
·
COGS moved
COGS / varekostnad 107.03m NOK → 3.13bn NOK (+2822.4% YoY). Calculated